Sumatriptan/naproxen sodium
Sumatriptan/naproxen sodium, sold under the brand name Treximet, is a combination medication used to treat migraines attacks.[1] It is taken by mouth.[1]
| Combination of | |
|---|---|
| Sumatriptan | Triptan |
| Naproxen sodium | NSAID |
| Clinical data | |
| Trade names | Treximet, Trexima, others |
| Routes of administration | By mouth |
| Identifiers | |
| KEGG | |
Active ingredients
It combines 85 mg of sumatriptan, a selective 5-hydroxytryptamine1 (5-HT1) receptor subtype agonist and 500 mg of naproxen sodium, a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs), in one tablet.
Side effects
Some of the listed side effects include dizziness, nausea, sleepiness, dry mouth, pain in neck, throat or jaw, numbness or tingling.[2]
References
- "DailyMed - sumatriptan succinate and naproxen sodium tablet, film coated". dailymed.nlm.nih.gov. Retrieved 6 March 2019.
- https://www.drugs.com/treximet.html
External links
| Subsidiaries | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Predecessors, acquisitions | |||||||||||
| Products |
| ||||||||||
| People |
| ||||||||||
| Litigation | |||||||||||
| Other | |||||||||||
| |||||||||||
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.